0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features

A. Obaid Shakil, MBBS, MRCP; Cathy Conry-Cantilena, MD; Harvey J. Alter, MD; Paul Hayashi, MD; David E. Kleiner, MD, PhD; Valeria Tedeschi, PhD; Krzysztof Krawczynski, MD, PhD; Hari S. Conjeevaram, MD; Richard Sallie, MD, FRACP; Adrian M. Di Bisceglie, MD, the Hepatitis C Study Group*
[+] Article and Author Information

From the National Institutes of Health, Bethesda, Maryland, and the Centers for Disease Control and Prevention, Atlanta, Georgia. Acknowledgments: The authors thank Dr. David Herion of the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health for help with assessing alcohol consumption and the nursing staff of the 9E patient care unit of the Warren Magnusen Clinical Center for their help in caring for these participants. Requests for Reprints: Jay H. Hoofnagle, MD, Liver Diseases Section, National Institutes of Health, Building 10, Room 4D52, Bethesda, MD 20892-1372. Current Author Addresses: Dr. Shakil: Division of Transplantation Medicine, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213-2582.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;123(5):330-337. doi:10.7326/0003-4819-123-5-199509010-00002
Text Size: A A A

Objective: To assess the clinical significance of antibody to hepatitis C virus (anti-HCV) in volunteer blood donors.

Design: Prospective cohort study.

Setting: National Institutes of Health Clinical Center, a tertiary referral research hospital.

Patients: 60 anti-HCV-positive blood donors, divided into three groups of 20 persons each: Group I had normal alanine aminotransferase levels, group II had levels elevated to values less than twice the normal range, and group III had levels elevated to values greater than twice the normal range.

Measurements: Medical history, results of laboratory and virologic testing, and percutaneous liver biopsy findings.

Results: Participants with normal alanine amino-transferase levels were older and more often female than those with abnormal levels. The source of infection, duration of disease, symptom score, and amount of alcohol consumed were similar in the three groups. Hepatitis C virus RNA was detectable in 85% of participants, more commonly in the groups with elevated alanine aminotransferase levels (95%) than in the group with normal levels (65%); however, titers were similar in all groups. Examination of liver biopsy specimens showed chronic hepatitis in 54 participants (90%) and cirrhosis in 1 participant. The only normal liver biopsy specimens (n = 3) were those from participants who were HCV RNA negative and had normal alanine aminotransferase levels.

Conclusions: Most blood donors with anti-HCV have chronic hepatitis C regardless of their serum alanine aminotransferase levels. Donors with normal alanine aminotransferase levels and no HCV RNA in their serum generally have normal liver histologic findings or minimal changes and have probably recovered from HCV infection.

*Members of the Hepatitis C Study Group include Jacqueline C. Melpolder, MT, and Jay H. Hoofnagle, MD, National Institutes of Health, Bethesda, Maryland.

Figures

Grahic Jump Location
Figure 1.
Alanine aminotransferase (ALT) levels (top) and histologic activity index scores (bottom) in viremic and nonviremic volunteer blood donors.t

Fifty-one donors were positive on at least one occasion for hepatitis C virus RNA in serum by polymerase chain reaction [PCR], and 9 donors were repeatedly negative for hepatitis C virus RNA by PCR. Values shown are the maximal recorded during the screening period; the interrupted line indicates the upper limit of the normal range, and the horizontal bars represent the means. Analysis was done using the Student -test). To convert alanine aminotransferase values to µkat/L, multiply by 0.01667.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)